
    
      Very small blood samples (500 microliters) will be collected serially in these patients and
      analyzed with current cytokine array technology. A convenience sample of 60 patients, 20 with
      each of these diagnoses, will be collected over a 2 year period. These data will provide
      baseline information for possible therapeutic intervention with agents that enhance or
      suppress specific mediators, or adjust mediator balance to promote patient healing.
    
  